KPTI - Latest News

Karyopharm Therapeutics Inc. (KPTI), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $75.6M. Beta to the broader market is 0.81.

The article list below shows the most recent KPTI headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent KPTI Headlines

Karyopharm Therapeutics Inc. (KPTI) Q1 2026 Earnings Call Transcript

seekingalpha.com - May 14, 2026

Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Q1 Earnings Call Highlights

marketbeat.com - May 14, 2026

Karyopharm Therapeutics NASDAQ: KPTI said it entered 2026 with several near-term clinical and regulatory catalysts, led by new Phase 3 data in myelofi

Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Beats Revenue Estimates

zacks.com - May 14, 2026

Karyopharm Therapeutics (KPTI) came out with a quarterly loss of $1. 24 per share versus the Zacks Consensus Estimate of a loss of $1.

Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment

prnewswire.com - May 14, 2026

– Completed Enrollment of Phase 3 XPORT-EC-042 Trial in Endometrial Cancer; Topline Data Expected Mid-2026 – – Phase 3 SENTRY Results Selected for Lat

Karyopharm to Participate at Upcoming Investor Conferences

prnewswire.com - May 12, 2026

NEWTON, Mass. , May 12, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc.

How News Affects KPTI Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track KPTI's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked KPTI news questions

What is the latest KPTI news headline?
The most recent KPTI headline (May 14, 2026) is "Karyopharm Therapeutics Inc. (KPTI) Q1 2026 Earnings Call Transcript". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
How fresh is the KPTI news on this page?
News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
What KPTI news moves options pricing?
Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
How can I track unusual KPTI options activity related to news?
Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.